HMDCFHutchison China Ltd.

About Hutchison China Ltd. (HMDCF)

Hutchison China Ltd. (HMDCF) is a Drug Manufacturers - Specialty & Generic company headquartered in Kowloon, HK, China whose shares trade over-the-counter on the Pink tier.

HUTCHMED China Ltd, formerly Hutchison China Meditech Ltd, is an investment holding company principally engaged in the manufacturing and sale of drugs. Along with subsidiaries, the Company operates its business through two segments. The Oncology and Immunology segment is engaged in discovering, developing, and commercializing targeted therapies and immunotherapies for the treatment of cancer and immunological diseases, including research and development activities covering drug discovery, development, manufacturing and regulatory functions as well as administrative activities to support research and development operations, also covering sales, marketing, manufacturing and distribution of drug developed from research and development activities. The Other Ventures segment is involved in other commercial businesses including the sales, marketing, manufacturing and distribution of other prescription drugs and over-the-counter pharmaceuticals as well as consumer health products.

HMDCF key facts

Ticker symbol

HMDCF

Market tier

Pink

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

Kowloon, HK, China

Country of incorporation

KY

Estimated market cap

$2.54B (as of May 12, 2025)

Shares outstanding

792,684,524

Reporting standard

International Reporting: Hong Kong Stock Exchange

Audit status

Not Available

Fiscal year end

12/31

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · Pink stocks · OTC stocks starting with H